Cureus | Patterns of Complementary and Alternative Medicine Use in Saudi Arabian Patients With Inflammatory Bowel Disease: A Cross-Sectional Study
Low adherence to treatment is a weak link in the problems of ulcerative colitis - Parfenov - Terapevticheskii arkhiv
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study - Pugliese - 2022 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Real world practice of medical treatment for moderate and severe inflammatory bowel diseases in Russian Federation, Republic of Belarus and Republic of Kazakhstan: intermediate results of the INTENT study - Knyazev -
Mucosal gene expression in inflammatory bowel disease | CEG
Trends and demographic patterns in biologic and corticosteroid prescriptions for inflammatory bowel disease: findings from electronic medical records, 2011–2020 | Journal of Investigative Medicine
PDF) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
![PDF] Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study by Marco Le Grazie, Siro Bagnoli, Gabriele Dragoni, Saverio Caini, Vito Annese,](https://og.oa.mg/Infliximab%20is%20more%20effective%20than%20cyclosporine%20as%20a%20rescue%20therapy%20for%20acute%20severe%20ulcerative%20colitis:%20a%20retrospective%20single-center%20study.png?author=%20Marco%20Le%20Grazie,%20Siro%20Bagnoli,%20Gabriele%20Dragoni,%20Saverio%20Caini,%20Vito%20Annese,%20Tommaso%20Innocenti,%20Simona%20Deiana,%20Natalia%20Manetti,%20Stefano%20Milani,%20Andrea%20Galli,%20Monica%20Milla "PDF] Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study by Marco Le Grazie, Siro Bagnoli, Gabriele Dragoni, Saverio Caini, Vito Annese,")
PDF] Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study by Marco Le Grazie, Siro Bagnoli, Gabriele Dragoni, Saverio Caini, Vito Annese,
Ulcerative Colitis and Pregnancy | IntechOpen
PDF) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance
3era Parada | Sociedad Argentina de Gastroenterología
Management of patients with inflammatory bowel disease and spondyloarthritis
Megacolon tossico e colite pseudomembranosa Megacolon tossico e colite pseudomembranosa
Frontiers | Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?
Advances in Clinical and Experimental Medicine
Optimal Management of Acute Severe Ulcerative Colitis (ASUC): Challeng | CEG
The influence of cytokines on the complex pathology of ulcerative colitis - ScienceDirect
Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowe
Infliximab formulation strategy for a stable ileo-colonic targeted oral dosage form intended for the topical treatment of inflammatory bowel disease - ScienceDirect
Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remi
Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis - Wang, Y - 2016 | Cochrane Library
Ulcerative Colitis and Pregnancy | IntechOpen
Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1. - Document - Gale OneFile:
2017 European Ulcerative Colitis Guidelines - Diagnosis - Part One of Two Parts - Page 11 of 11 - Tom Wade MD
